Page last updated: 2024-11-08

amifampridine and Epilepsy

amifampridine has been researched along with Epilepsy in 2 studies

Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wirtz, PW1
Titulaer, MJ1
Gerven, JM1
Verschuuren, JJ1
Albowitz, B1
Kuhnt, U1
Ehrenreich, L1

Reviews

1 review available for amifampridine and Epilepsy

ArticleYear
3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.
    Expert review of clinical immunology, 2010, Volume: 6, Issue:6

    Topics: 4-Aminopyridine; Action Potentials; Amifampridine; Calcium Channels; Cholinergic Agents; Clinical Pr

2010

Other Studies

1 other study available for amifampridine and Epilepsy

ArticleYear
Optical recording of epileptiform voltage changes in the neocortical slice.
    Experimental brain research, 1990, Volume: 81, Issue:2

    Topics: 4-Aminopyridine; Amifampridine; Animals; Bicuculline; Cerebral Cortex; Convulsants; Electrophysiolog

1990